Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In Columbus
This study exists to better understand the safety of the medication RL-007 and how manageable it feels in practice. Researchers are trying to understand whether the medication RL-007 can improve attention, thinking, or day-to-day functioning.
In Long BeachThis summary needs review. Please check the official study record and contact the research team for details.
In LondonThis summary needs review. Please check the official study record and contact the research team for details.
In LondonThis study is completed. It is testing Paliperidone Extended-Release (ER) for schizophrenia.
Location not clearly listedThis study exists to understand whether the medication MP-214 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication MP-214 in practice and what may need to be adjusted.
In KureThis summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis study is completed in the United States. It is testing Intravenous NRP104 for Addiction.
In BaltimoreThis study is completed. It focuses on ADHD.
Location not clearly listedThis study is completed in the United States. It is testing ABT-089 for ADHD.
Multiple locations, including LafayetteThis study is completed in the United States. It is testing V117957 for Addiction.
Multiple locations, including GlendaleThis study is completed in the United States. It is testing Multiple Rising Doses of TAK- 063 for schizophrenia.
In GlendaleHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.